Prognostic analysis of tumor mutation burden and immune infiltration in hepatocellular carcinoma based on TCGA data-Reference-Cited by-同舟云学术

Prognostic analysis of tumor mutation burden and immune infiltration in hepatocellular carcinoma based on TCGA data

Published:2021-04-04 Issue:8 Volume:13 Page:11257-11280
ISSN:1945-4589
Container-title:Aging
language:en
Short-container-title:Aging

Author:

Liu Shaoqing¹²,Tang Qianjie³,Huang Jianwen²,Zhan Meixiao²,Zhao Wei²,Yang Xiangyu²,Li Yong²,Qiu Lige²,Zhang Fujun¹,Lu Ligong²,He Xu²

Affiliation:

1. Department of Minimally Invasive and Interventional Radiology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China

2. Zhuhai Interventional Medical Center, Zhuhai Precision Medical Center, Zhuhai People's Hospital Affiliated with Jinan University), Jinan University, Zhuhai 519000, China

3. Department of Pharmacy, Guangdong Women and Children Hospital, Guangzhou 511400, China

Publisher

Impact Journals, LLC

Subject

Cell Biology,Aging

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic Model Construction of Disulfidptosis-Related Genes and Targeted Anticancer Drug Research in Pancreatic Cancer;Molecular Biotechnology;2024-04-04

2. The sorafenib resistance-related gene signature predicts prognosis and indicates immune activity in hepatocellular carcinoma;Cell Cycle;2024-01-17

3. CDK4 as a Prognostic Marker of Hepatocellular Carcinoma and CDK4 Inhibitors as Potential Therapeutics;Current Medicinal Chemistry;2024-01-12

4. Advances in Immunotherapy for Hepatocellular Carcinoma (HCC);Current Oncology;2023-11-07

5. The progress of research on immune checkpoint inhibitor resistance and reversal strategies for hepatocellular carcinoma;Cancer Immunology, Immunotherapy;2023-11-02